Danjoux CE, Rider WD, Fitzpatrick PJ. The acute radiation syndrome. A memorial to William Michael Court-Brown. Clin Radiol 1979;30:581–584.

• PubMed
DanjouxCERiderWDFitzpatrickPJ. The acute radiation syndrome. A memorial to William Michael Court-Brown. Clin Radiol 1979;30:581–584. )| false
• Search Google Scholar
• Export Citation

The Italian Group for Antiemetic Research in Radiotherapy. Radiation-induced emesis: a prospective observational multicenter Italian trial. Int J Radiat Oncol Bio Phys 1999;44:619–625.

• PubMed
The Italian Group for Antiemetic Research in Radiotherapy. Radiation-induced emesis: a prospective observational multicenter Italian trial. Int J Radiat Oncol Bio Phys 1999;44:619–625. )| false
• Search Google Scholar
• Export Citation

Horiot JC. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting? Int J Radiat Oncol Biol Phys 2004;15:1018–1025.

• PubMed
HoriotJC. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting? Int J Radiat Oncol Biol Phys 2004;15:1018–1025. )| false
• Search Google Scholar
• Export Citation

Ettinger DS, Bierman PJ, Bradbury B et al.. The NCCN antiemesis clinical practice guidelines in oncology, version 2, 2006. Available at: http://www.nccn.org/physician_gls/index.html. Accessed November 2, 2006.

• PubMed
EttingerDSBiermanPJBradburyB. The NCCN antiemesis clinical practice guidelines in oncology, version 2, 2006. Available at: http://www.nccn.org/physician_gls/index.html. Accessed November 2, 2006. )| false
• Search Google Scholar
• Export Citation

Multinational Association of Supportive Care in Cancer. Antiemetic Guideline Consensus. Available at: http://www.mascc.org/ktml2/images/uploads/Resource_centers/MASCC_Guidelines_Update_9_05.pdf. Accessed November 2, 2006.

• PubMed
Multinational Association of Supportive Care in Cancer. Antiemetic Guideline Consensus. Available at: http://www.mascc.org/ktml2/images/uploads/Resource_centers/MASCC_Guidelines_Update_9_05.pdf. Accessed November 2, 2006. )| false
• Search Google Scholar
• Export Citation

American Society of Clinical Oncology Kris MG, Hesketh PJ et al.. American Society of Clinical Oncology guidelines for antiemetics in oncology: update 2006. J Clin Oncol 2006;24:2932–2947.

• PubMed
American Society of Clinical OncologyKrisMGHeskethPJ. American Society of Clinical Oncology guidelines for antiemetics in oncology: update 2006. J Clin Oncol 2006;24:2932–2947. )| false
• Search Google Scholar
• Export Citation

Belkacemi Y, Ozsahin M, Pene F et al.. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis. Int J Radiat Oncol Biol Phys 1996;36:77–82.

• PubMed
BelkacemiYOzsahinMPeneF. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis. Int J Radiat Oncol Biol Phys 1996;36:77–82. )| false
• Search Google Scholar
• Export Citation

Spitzer TR, Friedman CJ, Bushnell W et al.. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation. Bone Marrow Transplant 2000;26:203–210.

• PubMed
SpitzerTRFriedmanCJBushnellW. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation. Bone Marrow Transplant 2000;26:203–210. )| false
• Search Google Scholar
• Export Citation

Gralla R, Lichinitser M, Van Der Vegt S et al.. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003;14:1570–1577.

• PubMed
GrallaRLichinitserMVan Der VegtS. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003;14:1570–1577. )| false
• Search Google Scholar
• Export Citation

Eisenberg P, Figueroa-Vadillo J, Zamora R et al.. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer 2003;98:2473–2482.

• PubMed
EisenbergPFigueroa-VadilloJZamoraR. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer 2003;98:2473–2482. )| false
• Search Google Scholar
• Export Citation

Aapro M, Grunberg S, Manikhas G et al.. A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 2006;17:1441–1449.

• PubMed
AaproMGrunbergSManikhasG. A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 2006;17:1441–1449. )| false
• Search Google Scholar
• Export Citation

Franzen L, Nyman J, Hagberg H et al.. A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol 1996;7:587–592.

• PubMed
FranzenLNymanJHagbergH. A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol 1996;7:587–592. )| false
• Search Google Scholar
• Export Citation

Kirkbride P, Bezjak A, Pater J et al.. Dexamethasone for the prophylaxis of radiation induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. J Clin Oncol 2000;18:1960–1966.

• PubMed
KirkbridePBezjakAPaterJ. Dexamethasone for the prophylaxis of radiation induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. J Clin Oncol 2000;18:1960–1966. )| false
• Search Google Scholar
• Export Citation

Lanciano R, Sherman DM, Michalski J et al.. The efficacy and safety of once-daily kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Invest 2001;19:763–772.

• PubMed
LancianoRShermanDMMichalskiJ. The efficacy and safety of once-daily kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Invest 2001;19:763–772. )| false
• Search Google Scholar
• Export Citation